Truist Financial Corp lessened its holdings in Alteryx, Inc. (NYSE:AYX – Get Rating) by 9.0% during the 3rd quarter, Holdings Channel.com reports. The firm owned 11,624 shares of the company’s stock after selling 1,155 shares during the period. Truist Financial Corp’s holdings in Alteryx were worth $649,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors have also recently made changes to their positions in the company. Ancora Advisors LLC bought a new position in shares of Alteryx in the 1st quarter worth approximately $29,000. PNC Financial Services Group Inc. raised its stake in Alteryx by 14.9% during the 1st quarter. PNC Financial Services Group Inc. now owns 1,583 shares of the company’s stock worth $114,000 after acquiring an additional 205 shares during the period. NuWave Investment Management LLC purchased a new position in Alteryx during the third quarter valued at approximately $161,000. SVB Wealth LLC bought a new position in shares of Alteryx in the first quarter worth approximately $223,000. Finally, Roundview Capital LLC purchased a new stake in shares of Alteryx in the first quarter worth $236,000. Institutional investors own 74.23% of the company’s stock.
Alteryx Stock Up 4.4 %
Shares of NYSE AYX opened at $52.68 on Monday. The firm’s 50-day moving average price is $47.61 and its 200-day moving average price is $52.91. The company has a current ratio of 1.60, a quick ratio of 1.60 and a debt-to-equity ratio of 5.07. The stock has a market capitalization of $3.64 billion, a price-to-earnings ratio of -11.04 and a beta of 0.50. Alteryx, Inc. has a 12-month low of $39.55 and a 12-month high of $76.35.
In other news, insider Paula Hansen sold 6,500 shares of the company’s stock in a transaction dated Wednesday, November 30th. The shares were sold at an average price of $44.10, for a total transaction of $286,650.00. Following the sale, the insider now directly owns 105,793 shares in the company, valued at approximately $4,665,471.30. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 13.84% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of research analysts recently weighed in on AYX shares. JMP Securities lowered their target price on shares of Alteryx from $127.00 to $95.00 and set a “market outperform” rating on the stock in a research note on Wednesday, November 2nd. Morgan Stanley lowered their target price on shares of Alteryx from $65.00 to $60.00 and set an “equal weight” rating on the stock in a research note on Monday, December 19th. Needham & Company LLC lowered their target price on shares of Alteryx from $80.00 to $62.00 and set a “buy” rating on the stock in a research note on Wednesday, November 2nd. Wedbush started coverage on shares of Alteryx in a research note on Wednesday, December 14th. They set a “neutral” rating and a $50.00 target price on the stock. Finally, Truist Financial restated a “buy” rating and set a $80.00 target price on shares of Alteryx in a research note on Friday, November 11th. Five investment analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $72.31.
Alteryx, Inc engages in the provision of self-service data analytics software. Its subscription-based platform allows organizations to prepare, blend, and analyze data from a multitude of sources and benefit from data-driven decisions. The company was founded by Dean A. Stoecker, Olivia Duane-Adams, and Edward P.
- Get a free copy of the StockNews.com research report on Alteryx (AYX)
- CVS Health is Growing into an Integrated Healthcare Organization
- NVIDIA Outlook Improving: Watchlist Candidate for 2023
- Is C3.ai Stock a ChatGPT Artificial Intelligence Play?
- Which Wireless Stock Should You Buy in 2023?
- Is Virgin Galactic Stock Preparing for Lift-Off?
Receive News & Ratings for Alteryx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alteryx and related companies with MarketBeat.com's FREE daily email newsletter.